FDA Adverse Event Malfunction Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT

MDR report key: 3023903 · Received March 27, 2013

Report

Report Number
2521625-2013-00001
Event Type
Malfunction
Date Received
March 27, 2013
Date of Event
January 17, 2013
Report Date
March 27, 2013
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
LTJ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION CONFIRMED THAT MULTIPLE, NON-REPRODUCIBLE, LOWER THAN EXPECTED VITROS PSA QUALITY CONTROL RESULTS WERE OBTAINED WHILE USING THE VITROS 5600 INTEGRATED SYSTEM. ACCEPTABLE PSA QUALITY CONTROL RESULTS WERE OBTAINED FROM AN ALTERNATE PSA REAGENT PACK OF THE SAME LOT. ROOT CAUSE OF THE LOWER THAN EXPECTED QUALITY CONTROL RESULTS COULD NOT BE DETERMINED. THERE IS NO EVIDENCE THAT AN INSTRUMENT RELATED ISSUE CONTRIBUTED TO THE EVENT.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED MULTIPLE, NON-REPRODUCIBLE, LOWER THAN EXPECTED VITROS PSA QUALITY CONTROL RESULTS (LEVEL 1 = 1.77 VS. AN EXPECTED RESULT = 2.4; LEVEL 2 = 15.7 VS. AN EXPECTED RESULT = 21 NG/ML) WHILE USING QC LOT 27908 PROCESSED ON THE VITROS 5600 INTEGRATED SYSTEM. BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THERE WAS NO REPORT THAT PATIENT SAMPLES WERE AFFECTED. THERE WAS NO REPORT OF PATIENT HARM AS A RESULT OF THIS EVENT. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
125719 VITROS IMMUNODIAGNOSTIC PRODUCTS PSA REAGENT IN-VITRO DIAGNOSTIC LTJ ORTHO-CLINICAL DIAGNOSTICS 2930

Patients

Seq Age Sex Outcome Treatment
1